Lunai Bioworks (LNAI) Depreciation and Depletion (2013 - 2024)
Lunai Bioworks (LNAI) recorded quarterly Depreciation and Depletion of $30360.0 in Q2 2024, up 2.82% quarter-over-quarter from $29526.0 in Q1 2024, and up 14.97% on a YoY basis from $26406.0 in Q3 2023.
Lunai Bioworks (LNAI) Depreciation and Depletion (2013 - 2024) Analysis & Trends
Lunai Bioworks' Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $30360.0 for Q2 2024.
- In Q2 2024, Depreciation and Depletion rose 14.97% year-over-year to $30360.0; the TTM figure through Jun 2024 stood at $113563.0 (up 5.82% YoY), while the FY2025 annual figure was $119193.0, up 4.96% from the prior year.
- Depreciation and Depletion was $30360.0 for Q2 2024 at Lunai Bioworks, up from $29526.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $35764.0 in Q1 2020 to a low of $14949.0 in Q2 2020.
- Historically, Depreciation and Depletion has averaged $27102.1 across 5 years, with a median of $27056.5 in 2022.
- Biggest YoY gain for Depreciation and Depletion was 807.95% in 2020; the steepest drop was 57.46% in 2020.
- A 5-year view of Depreciation and Depletion shows it stood at $26813.0 in 2020, then climbed by 4.39% to $27990.0 in 2021, then decreased by 2.33% to $27338.0 in 2022, then declined by 0.51% to $27198.0 in 2023, then climbed by 11.63% to $30360.0 in 2024.
- The last three Depreciation and Depletion figures came in at $30360.0 (Q2 2024), $29526.0 (Q1 2024), and $27198.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 30,360.00 |
| Jun 30, 2024 | 30,360.00 |
| Mar 31, 2024 | 29,526.00 |
| Mar 31, 2024 | 29,526.00 |
| Dec 31, 2023 | 27,198.00 |
| Dec 31, 2023 | 27,198.00 |
| Sep 30, 2023 | 26,479.00 |
| Sep 30, 2023 | 26,479.00 |
| Jun 30, 2023 | 26,406.00 |
| Jun 30, 2023 | 26,406.00 |
| Mar 31, 2023 | 26,662.00 |
| Mar 31, 2023 | 26,662.00 |
| Dec 31, 2022 | 27,338.00 |
| Dec 31, 2022 | 27,338.00 |
| Sep 30, 2022 | 26,915.00 |
| Sep 30, 2022 | 26,915.00 |
| Jun 30, 2022 | 24,808.00 |
| Jun 30, 2022 | 24,808.00 |
| Mar 31, 2022 | 27,990.00 |
| Mar 31, 2022 | 27,990.00 |